LakeShore Biopharma Co., Ltd (LSBCF)
OTCMKTS · Delayed Price · Currency is USD
0.0310
0.00 (0.00%)
At close: Apr 10, 2026
LakeShore Biopharma Market Cap
LakeShore Biopharma has a market cap or net worth of $1.28 million as of April 10, 2026. Its market cap has decreased by -97.22% in one year.
Market Cap
1.28M
Enterprise Value
54.51M
Revenue
84.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since August 5, 2021, LakeShore Biopharma's market cap has decreased from 227.76M to 1.28M, a decrease of -99.44%. That is a compound annual growth rate of -66.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 1.28M | -96.31% |
| Dec 31, 2025 | 34.62M | -47.56% |
| Dec 31, 2024 | 66.02M | 38.83% |
| Dec 29, 2023 | 47.55M | -80.26% |
| Dec 30, 2022 | 240.85M | 3.14% |
| Dec 29, 2021 | 233.52M | 2.53% |
| Aug 5, 2021 | 227.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biomind Labs | 4.34M |
| AccuStem Sciences | 4.26M |
| GPL Holdings | 4.17M |
| Oncology Pharma | 3.92M |
| Galera Therapeutics | 3.11M |
| Vaccinex | 2.68M |
| Burzynski Research Institute | 2.67M |
| CASI Pharmaceuticals | 2.49M |